Related references
Note: Only part of the references are listed.High Index of Clinical Suspicion With Optimal Surgical Techniques and Adjuvant Radiotherapy Is Critical to Reduce Locoregional Disease Progression in Parathyroid Carcinoma
Ben Selvan et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2013)
Parathyroid cancer: Outcome analysis of 16 patients treated at the princess margaret hospital
Boban M. Erovic et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2013)
Immunohistochemistry in the era of personalised medicine
Clare Margaret McCourt et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Parathyroid Carcinoma: Update and Guidelines for Management
Christina H. Wei et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2012)
Expression of parafibromin in major renal cell tumors
C. Cui et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2012)
Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma
Hee Kyung Kim et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2012)
Diagnosis and management of parathyroid cancer
Klaus-Martin Schulte et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Molecular Profiling of Parathyroid Hyperplasia, Adenoma and Carcinoma
Kristof Arvai et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Development of a Formula to Predict Parathyroid Carcinoma in Patients with Primary Hyperparathyroidism
Elias Karakas et al.
WORLD JOURNAL OF SURGERY (2012)
Parathyroid carcinoma: A difficult histological diagnosis
C. Rodriguez et al.
EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES (2012)
Parathyroid carcinoma: increasing incidence and changing presentation
Sebastian Brown et al.
ANZ JOURNAL OF SURGERY (2011)
Ultrasound features of malignancy in the preoperative diagnosis of parathyroid cancer: a retrospective analysis of parathyroid tumours larger than 15 mm
Paul S. Sidhu et al.
EUROPEAN RADIOLOGY (2011)
Parathyroid Carcinoma: A 43-Year Outcome and Survival Analysis
Avital Harari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma
Janneke E. Witteveen et al.
MODERN PATHOLOGY (2011)
Parathyroid Carcinoma Encountered After Minimally Invasive Focused Parathyroidectomy may not Require Further Radical Surgery
Christine J. O'Neill et al.
WORLD JOURNAL OF SURGERY (2011)
FDG-PET/CT and parathyroid carcinoma: Review of literature and illustrative case series
Laura Evangelista et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2011)
Clinical Presentation, Staging and Long-Term Evolution of Parathyroid Cancer
Nadia Talat et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Parafibromin and APC as Screening Markers for Malignant Potential in Atypical Parathyroid Adenomas
C. Christofer Juhlin et al.
ENDOCRINE PATHOLOGY (2010)
Changing clinicopathological practice in parathyroid disease
Sarah J. Johnson
HISTOPATHOLOGY (2010)
Intraoperative Determination of PTH Concentrations in Fine Needle Tissue Aspirates to Identify Parathyroid Tissue During Parathyroidectomy
Janos Horanyi et al.
WORLD JOURNAL OF SURGERY (2010)
Lymph Node Involvement and Surgical Approach in Parathyroid Cancer
Klaus-Martin Schulte et al.
WORLD JOURNAL OF SURGERY (2010)
Defining a Molecular Phenotype for Benign and Malignant Parathyroid Tumors
Gustavo G. Fernandez-Ranvier et al.
CANCER (2009)
Accuracy of Combined Protein Gene Product 9.5 and Parafibromin Markers for Immunohistochemical Diagnosis of Parathyroid Carcinoma
Viive M. Howell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Parathyroid Carcinoma: Etiology, Diagnosis, and Treatment
Takahiro Okamoto et al.
WORLD JOURNAL OF SURGERY (2009)
Needle tract sinus following aspiration biopsy of papillary thyroid carcinoma - A case report
Adhish Basu et al.
ACTA CYTOLOGICA (2008)
The role of PGP9.5 as a tumor suppressor gene in human cancer
Yutaka Tokumaru et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Parafibromin expression in breast cancer: a novel marker for prognostication?
S. Selvarajan et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Parafibromin tumor suppressor enhances cell growth in the cells expressing SV40 large T antigen
T. Iwata et al.
ONCOGENE (2007)
Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas
C. J. Haven et al.
CLINICAL ENDOCRINOLOGY (2007)
Parafibromin immunoreactivity:: its use as an additional diagnostic marker for parathyroid tumor classification
C. C. Juhlin et al.
ENDOCRINE-RELATED CANCER (2007)
Trends in the incidence and treatment of parathyroid cancer in the United States
Peter K. Lee et al.
CANCER (2007)
Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma
G. Ippolito et al.
BRITISH JOURNAL OF SURGERY (2007)
Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?
Filomena Cetani et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Implantation of parathyroid carcinoma along fine needle aspiration track
Gaurav Agarwal et al.
LANGENBECKS ARCHIVES OF SURGERY (2006)
Galectin-3 and Ki-67 expression in multiglandular parathyrold lesions
Enrico Saggiorato et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases
N Bergero et al.
HUMAN PATHOLOGY (2005)
Proposal for the histological classification of parathyroid carcinoma
Kaori Kameyama et al.
ENDOCRINE PATHOLOGY (2005)
Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression
GE Woodard et al.
ONCOGENE (2005)
Expression of p53, Ki-67 and bcl-2 in parathyroid adenoma and residual normal tissue
T Hadar et al.
PATHOLOGY & ONCOLOGY RESEARCH (2005)
Cell surface overexpression of galectin-3 and the presence of its ligand 90k in the blood plasma as determinants in colon neoplastic lesions
C Greco et al.
GLYCOBIOLOGY (2004)
Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms
P Mehrotra et al.
HISTOPATHOLOGY (2004)
Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma
MH Tan et al.
CLINICAL CANCER RESEARCH (2004)
Telomerase activation and expression of its catalytic subunits in benign and malignant tumors of the parathyroid
N Onoda et al.
SURGERY TODAY (2004)
Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma
TM Shattuck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Demonstration of human telomerase reverse transcriptase (hTERT) in human parathyroid tumours by in situ hybridization with a new oligonucleotide probe
M Kammori et al.
CLINICAL ENDOCRINOLOGY (2003)
PCNA and Ki-67 as prognostic markers in human parathyroid carcinomas
K Kameyama et al.
ANNALS OF SURGICAL ONCOLOGY (2000)